AI Article Synopsis
- The study focuses on drug-induced acute kidney injury (D-AKI) in China, aiming to assess its prevalence, associated medications, and risk factors.
- Approximately 280,255 hospitalized patients were screened, with 1,960 cases of hospital-acquired AKI identified; among these, 735 were specifically classified as D-AKI, revealing a significant in-hospital mortality rate of 13.88% and limited renal recovery in survivors.
- Key drugs linked to D-AKI included anti-infectives, diuretics, and proton pump inhibitors, and various factors such as age and severe illness were noted as independent risks for mortality in these patients.
Article Abstract
Introduction: Drug-induced acute kidney injury (D-AKI) is one of the important types of AKI. The incidence of D-AKI in China has rarely been studied.
Objective: This study aims to explore the disease burden, related drugs, and risk factors of D-AKI.
Methods: A nationwide cross-sectional survey was conducted in adult patients from 23 academic hospitals in 17 provinces in China. Suspected AKI was screened based on serum creatinine changes in accordance with the 2012 Kidney Disease: Improving Global Outcomes Clinical Practice Guideline for AKI, patients who met the diagnosis of hospital-acquired AKI in January and July of 2014 were defined. Suspected AKI was firstly evaluated for the possibility of D-AKI by pharmacists using the Naranjo Scale and finally defined as D-AKI by nephrologists through reviewing AKI clinical features.
Results: Altogether 280,255 hospitalized patients were screened and 1,960 cases were diagnosed as hospital-acquired AKI, among which 735 cases were defined as having D-AKI (37.50%, 735/1,960) with an in-hospital mortality rate of 13.88% and 54.34% of the survivors did not achieve full renal recovery. 1,642 drugs were related to AKI in these patients. Anti-infectives, diuretics, and proton pump inhibitors were the top 3 types of drugs relevant to D-AKI, accounting for 66.63% cumulatively. Besides age, AKI staging, severe disease, hypoalbuminemia, plasma substitute, and carbapenem related D-AKI were independent risk factors for in-hospital mortality of D-AKI patients.
Conclusion: In China, D-AKI has caused a substantial medical burden. Efforts should be made to pursue nephrotoxic drug stewardship to minimize attributable risk and improve the prevention, diagnosis, and treatment of D-AKI.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC8010232 | PMC |
| http://dx.doi.org/10.1159/000510455 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Acute Kidney Injury in Deceased Organ Donors: Risk Factors And Impacts on Transplantation Outcomes.
Transplant Direct
December 2024
Department of Nephrology, Institute for Clinical and Experimental Medicine, Prague, Czech Republic.
Background: Acute kidney injury in deceased donors (D-AKI) is one of the common causes of donor kidney discard. The risk factors for D-AKI and its impact on kidney transplantation outcomes are not yet fully understood.
Methods: This single-center, retrospective cohort study included 388 donors referred between June 2021 and December 2022.
A Systematic Review of the Costs of Drug-Associated Acute Kidney Injury and Potential Cost Savings with Nephrotoxin Stewardship Prevention Strategies.
Clin Pharmacol Ther
November 2024
University of Pittsburgh School of Pharmacy, Pittsburgh, Pennsylvania, USA.
There is a scarcity of information related to the financial impact of acute kidney injury (AKI), and even more so the economics of drug-associated AKI (D-AKI). Our goal was to provide a comprehensive summary of the economic burden of D-AKI by evaluating the costs of D-AKI compared to not developing AKI and cost savings associated with nephrotoxin stewardship approaches. Following the PRISMA guidelines, a literature search was conducted using PubMed to identify articles from database inception through November 2023.
View Article and Find Full Text PDFNew perspectives of drug related kidney diseases and disorders.
Curr Opin Crit Care
December 2024
Department of Pharmacy and Therapeutics, School of Pharmacy, University of Pittsburgh.
Purpose Of Review: The aim of this review is to provide a discussion of new perspectives for up-to-date definitions, a contemporary classification system, and the potential role of stress and damage biomarkers in the context of drug related kidney diseases and disorders.
Recent Findings: Acute kidney disease (AKD) is a term recently introduced in the literature describing an abnormality in kidney structure and function that lasts for less than 3 months. Drugs in the context of AKD is described as a new perspective; referred to as drug induced AKD.
The dose of the normal saline pre-infusion and other risk factors for amphotericin B deoxycholate-associated acute kidney injury.
Asian Biomed (Res Rev News)
December 2023
Department of Medicine, King Chulalongkorn Memorial Hospital, Faculty of Medicine, Chulalongkorn University, Bangkok 10330, Thailand.
Background: Conventional amphotericin B deoxycholate (AmBd) is the preferred amphotericin B formulation in countries with limited resources despite its nephrotoxicity. Normal saline pre-infusion is a recommended measure to reduce the risk of nephrotoxicity in patients receiving AmBd.
Objectives: To examine the effect of different normal saline solution (NSS) pre-infusion doses, and other potential risk factors, on the development of acute kidney injury (AKI) in patients with invasive fungal infection receiving AmBd.
Prevention and management of antibiotic associated acute kidney injury in critically ill patients: new insights.
Curr Opin Crit Care
December 2023
Department of Medicine, School of Medicine, University College Dublin, Dublin, Ireland.
Purpose Of Review: Drug associated kidney injury (D-AKI) occurs in 19-26% of hospitalized patients and ranks as the third to fifth leading cause of acute kidney injury (AKI) in the intensive care unit (ICU). Given the high use of antimicrobials in the ICU and the emergence of new resistant organisms, the implementation of preventive measures to reduce the incidence of D-AKI has become increasingly important.
Recent Findings: Artificial intelligence is showcasing its capabilities in early recognition of at-risk patients for acquiring AKI.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!